Effects of enteral nutrition with high-protein in critically ill patients

Not Applicable

• Conditions: Ventilated patients in the intensive care units

• Registration Number: JPRN-UMIN000036607
• Lead Sponsor: Osaka Saiseikai Senri Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-04-26
• Study Completion: 2020-04-30
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 34

Inclusion Criteria

Not provided

Exclusion Criteria

1)contraindication for enteral nutrient with high quantity of proteins 2)BMI more than 30, less than 18.5 3)denial of intensive care by a patients or a patient family 4)allergy to milk, soy, lactose 5)need for total parenteral nutrition 6)need for a renal replacement therapy 7)Patients judged as inappropriate to perform the present trial by the j the doctor

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Serum prealbumin concentration 7,14,28 days after the beginning of the study

Secondary Outcome Measures

Name	Time	Method
ventilator-free days,ICU length of stay,hospital length of stay, SOFA score, serum albumin, white blood cell count, lymphocyte count, CRP, total cholesterol, urea nitrogen, creatinine 7,14,28 days after the beginning of the study, total daily dose of insulin, total energy, and protein dose during enteral nutrition total amount of administration of blood products (albumin, globulin et al) complications(vomiting, diarrhea, kidney injury, ventilator-associated pneumonia)